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Abstract
The establishment of a functional vascular system requires multiple complex steps throughout
embryogenesis, from endothelial cell (EC) specification to vascular patterning into venous and
arterial hierarchies. Following the initial assembly of ECs into a network of cord-like structures,
vascular expansion and remodeling occur rapidly through morphogenetic events including vessel
sprouting, fusion, and pruning. In addition, vascular morphogenesis encompasses the process of
lumen formation, critical for the transformation of cords into perfusable vascular tubes. Studies in
mouse, zebrafish, frog, and human endothelial cells have begun to outline the cellular and
molecular requirements underlying lumen formation. Although the lumen can be generated
through diverse mechanisms, the coordinated participation of multiple conserved molecules
including transcription factors, small GTPases, and adhesion and polarity proteins remains a
fundamental principle, leading us closer to a more thorough understanding of this complex event.
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Introduction
The cardiovascular system is one of the first organ systems to arise during embryogenesis.
Its proper establishment during early development is critical for meeting the demands of a
rapidly growing embryo in need of nutrients, oxygen, and waste removal. Vertebrate blood
vessels develop via two distinct mechanisms known as vasculogenesis and angiogenesis.
During vasculogenesis, the de novo assembly of new blood vessels, a subset of mesodermal
cells differentiates into endothelial cell (EC) precursors called angioblasts. Angioblasts
proliferate and migrate to specified positions in the embryo where they coalesce into cord-
like structures to form the primary vascular plexus. These early EC behaviors are elicited
through growth factor-mediated signaling including vascular endothelial growth factor
(VEGF), fibroblast growth factor (FGF), and bone morphogenetic protein (BMP) [1].
Rapidly thereafter, endothelial cords transform into patent tubes and become further
specified to contribute to either the venous, arterial, or lymphatic vasculature [2]. The
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primitive plexus undergoes dramatic remodeling during angiogenesis when new vessels
sprout, elongate, and expand to form a complex network of arteries and veins. Henceforth,
the majority of vascular development proceeds via angiogenesis, which can also be sub-
divided into two processes. In sprouting angiogenesis, new vessels branch from preexisting
vessels whereas in intussusceptive angiogenesis, existing vessels internally split to form new
vessels [3, 4]. In later stages of vascular remodeling, mural cells including smooth muscle
cells and pericytes are recruited to surround the EC-lined tubes and impart vessel
stabilization and maturation [5].
In the adult, the vasculature is mostly quiescent, with little to no vessel growth or
remodeling. However, in response to injury, reduced oxygen or hypoxic conditions,
inflammation, tumor growth, or pregnancy, ECs are poised to react and form new blood
vessels in a process known as neoangiogenesis. The ability of a cohort of ECs to
dynamically assemble into a vascular network is remarkable, given the multitude of
individual cellular behaviors that must first be coordinated, including migration, cell-cell
and cell-extracellular matrix (ECM) adhesion, proliferation, ECM degradation, and
sprouting. Therefore, it is not surprising that dysregulation of these behaviors can have
detrimental effects on health and survival; e.g., during the pathogenesis of numerous
vascular diseases, including atherosclerosis and myocardial ischemia, as well as during
tumor progression [5, 6]. Understanding the cellular and molecular mechanisms underlying
EC behavior will provide a basis for the development of therapeutics for these diseases.
Over the years, substantial contributions have been made toward understanding the
mechanisms underlying sprouting angiogenesis that have significantly impacted the
development of therapeutics promoting or inhibiting vessel growth in a wide range of
diseases [7, 8]. Considerably less is known about the lumen formation process, critical for
establishing a patent and functional vascular system during development as well as for
efficient delivery of therapeutics to their targets during disease treatment. In this review, we
will discuss the diverse mechanisms by which the lumens of various vascular beds arise.
Although there is some debate as to which of these mechanisms predominate during
development, the identification of several molecules and models of lumen formation has
without a doubt shed light on this seemingly mysterious process, and has in recent years
greatly expanded the number of groups currently studying lumen morphogenesis.
Vessel lumens arise by distinct mechanisms
The ability to culture primary mammalian ECs has significantly enabled the study of cellular
behaviors associated with blood vessel assembly, such as proliferation, motility, and
sprouting angiogenesis. The recent advent of three-dimensional models has further enhanced
the ability to visualize EC morphogenesis into vascular tubes [9–12]. Specifically, in
response to suspension in three-dimensional collagen or fibrin matrices, human umbilical
vein endothelial cells (HUVECs) were shown to individually generate luminal spaces via a
vacuolation mechanism known as cell hollowing. Live imaging revealed that cells use
pinocytosis to internalize the plasma membrane and generate multiple vesicles that coalesce
to form an intracellular lumen, defined as an ECM-free space surrounded by a single EC
[13]. Contacts made between adjacent cells facilitate the fusion of vacuoles, resulting in a
Charpentier and Conlon Page 2






















network of capillary-like tubes (Fig. 1A). This process depends on signaling between ECs
and the ECM via integrins, particularly integrin α2β1 in collagen matrices, and integrins
αvβ3 and α5β1 in fibrin matrices [14, 15]. Although these observations were made in
cultured cells in a manipulated environment, the generation of an intracellular lumen via
vacuolation was also observed in zebrafish ISVs [16].
Recent studies, however, have indicated that the lumen is more often generated
extracellularly where it lies between two adjacent ECs connected by junctions, raising
questions regarding whether cell vacuolation is the primary mechanism of lumen formation
(Fig. 1B). Also known as cord hollowing, in the mouse dorsal aorta (DA) adjacent ECs are
initially in contact with one another via adherens junctions [17]. The cells become polarized
even before beginning to separate from each other with a number of molecules localizing
specifically to the apical surface where the lumen will be generated. The establishment of
apicobasal polarity is suggested to further promote cell separation by causing junctions to
redistribute away from the cell-cell interface to the periphery. Furthermore, small GTPase
signaling was also shown to enhance EC elongation in order to accommodate the luminal
compartment in the center [17]. In addition to the mouse DA, extracellular lumens also arise
in zebrafish ISVs. In contrast to the idea that intracellular vacuoles reside within the ISV
ECs and fuse to form a seamless unicellular tube, labeling of multiple junction and polarity
markers has in fact revealed that cells first establish apical polarity and form complex
junctions that dynamically rearrange to generate a multicellular tube containing an
extracellular lumen [18, 19]. However, ISV lumens are not generated strictly by cord
hollowing as Wang et al. showed that the formation and fusion of vacuoles within ISVs also
promote rapid expansion of the luminal compartment [19].
It is therefore increasingly clear that vessels arise in a heterogeneous manner and likely use a
number of mechanisms to conveniently and efficiently generate lumens. Extracellular lumen
formation may be the predominant mechanism by which major vessels such as the DA form,
whereas small-caliber vessels like the ISVs and capillaries, which have also been
demonstrated to resemble unicellular tubes in rats [20], may use a combination of both cord
and cell hollowing. Nonetheless, analyses of the molecular determinants of extracellular and
intracellular lumen formation have greatly contributed to our understanding of the cellular
processes that must be coordinated in order to promote this complex step of blood vessel
development (Table 1).
Vessels remodel lumens during branching and fusion
The processes described above reveal how the lumen forms de novo and independently of
blood flow. More frequently, new vessels are formed during anastomosis, or fusion between
two distinct perfused vessels that must combine luminal compartments to give rise to a
patent network. The formation of the zebrafish dorsal longitudinal anastomosing vessel
(DLAV) occurs via anastomosis between adjacent segmental arteries [21]. The DLAV is
comprised of both multicellular and, in the majority of cases, unicellular tubes. Using a
transgenic line expressing the tight junction molecule zonula occludens-1 (ZO-1) tagged to
GFP, Herwig et al. found that multicellular lumens are generated by the rearrangement of
junctions between three adjacent cells, resulting in the establishment of new contacts
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between the outer cells and the merging of local lumens into one continuous luminal
compartment. Conversely in most instances, junctions between two cells are not as dynamic.
Instead, a lumen is generated within a single cell by invagination of the apical membrane
throughout the length of the cell resulting in a unicellular tube with an intracellular lumen.
The luminal membrane of this single cell invaginates through the point of cell-cell contact to
ultimately fuse with the neighboring lumen [21].
The presence of unicellular tubes is not unique to the DLAV and is conserved in other
zebrafish vessels, such as the palatocerebral artery (PLA) in the cranial vasculature [22].
Using a similar fusion process, two distinct lumenized sprouts come into contact with each
other, marked by junction markers such as ZO-1, and combine their luminal compartments
by apical membrane invagination, resulting in two adjoining unicellular tubes comprised of
intracellular lumens. However, later remodeling events reveal that these unicellular vessels
are transient, and multicellular tubes take precedence within the PLA. The two cells adjacent
to the unicellular tube are initially not in contact with each other but move and redistribute
their junctions to form a new contact, thereby forcing the cell comprising the unicellular
tube to split to one side of the tube (Fig. 2). Therefore, an extracellular lumen surrounded by
multiple ECs is generated, analogous to the mouse DA lumen assembled via cord hollowing.
In both the DLAV and PLA, apical membrane invagination and the subsequent generation
of the lumen is dependent on blood flow, likely because of the force generated by increased
blood pressure. However, polarity and junctional rearrangements still take place in the
absence of flow [21, 22].
The presence of vacuole-like structures was not addressed in the above zebrafish studies and
hence it is debatable whether vacuole coalescence and apical membrane invagination truly
represent distinct mechanisms of lumen formation. However, because in both cases the
lumen is completely surrounded by a single cell and devoid of any junctions throughout the
unicellular region, vacuole coalescence, and apical membrane invagination can likely be
annotated as sub-categories of intracellular lumen formation (Fig. 1A). It is also unknown
what molecular forces govern lumen formation during vessel fusion. Because several
distinct cellular behaviors are necessary for successful anastomosis, including migration,
sprouting, and adhesion, it may be difficult to tease apart the specific molecular mechanism
underlying apical membrane invagination and subsequent cell splitting. It is likely that
multiple mechanisms are involved, and that different combinations of interacting factors and
intersecting signaling pathways at each step of vascular morphogenesis may elicit more
precise cellular responses.
The establishment of polarity initiates lumen formation
Distinct surface markers define the apical and basal membranes
Despite the distinction between intracellular and extracellular lumens, a common theme
reconciling these differences is that in all cases, cells must first establish polarity to define
the apical/luminal (“inside”) and basal/abluminal (“outside”) vessel surface [23]. This
specialized distinction between the inside and outside of the tube is not unique to ECs.
Multiple other tubular organs such as the kidney and intestine also display apicobasal
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polarity, and many of the molecular players currently being investigated in vessel lumen
formation unsurprisingly have reported roles in epithelial tubulogenesis as well [24].
A number of markers have been established that have preferential localization to either the
apical or basal side of EC-lined tubes. Notably, cell-surface transmembrane proteins such as
the CD34 sialomucins, consisting of CD34 and podocalyxin-like proteins 1 and 2 (PODXL/
PODXL2), and the Ezrin-Radixin-Moesin (ERM) protein Moesin are enriched at the apical
membrane [17, 19, 25, 26]. However, the function of these proteins extends beyond
expression at the apical surface. The negatively charged sialic acids coating the extracellular
domain of the CD34 sialomucins are required for the electrostatic repulsion needed to
separate the adjoining ECs from each other to accommodate the central luminal
compartment [27]. Furthermore, in PODXL-null mice, Moesin no longer localizes to the
apical membrane of the early DA, and only 40% of lumens fully develop [17]. ERM
proteins modulate cytoskeletal dynamics and signal transduction by anchoring the actin
cytoskeleton to various transmembrane proteins [28, 29]. Accordingly, Moesin depletion
was associated with significantly diminished F-actin enrichment at the apical surface of the
developing mouse DA and zebrafish ISVs, ultimately resulting in reduced or failed lumen
formation [17, 19]. In addition, the partition-defective (Par) polarity complex (Par3/Par6/
atypical protein kinase C [aPKC]) has also been implicated in apical polarity in epithelial
and ECs, and disruption of the Par complex is strongly associated with failed lumen
formation [30, 87]. Depletion of Par3 and Par6 in HUVECs embedded in collagen matrices
results in failed intracellular lumen formation, whereas chemical inhibition of PKC in the
mouse DA prevents Moesin phosphorylation and subsequent lumen generation [17, 31].
On the basal surface of the vessel, ECs contact various constituents of the ECM that
facilitate interactions with mural cells as well as influence whether vessels will become
stable and quiescent or “activated” to sprout [32]. Basement membrane markers include
fibronectin, laminin, collagen IV, and integrins. A recent study suggests that this specialized
separation of apical and basal membranes in vertebrate blood vessels is a consequence of EC
evolution. Unlike vertebrate vessels, the lumen of the aorta in the invertebrate
cephalochordate amphioxus, which lacks ECs, is directly lined with the laminin-containing
basement membrane implying that ECs serve to separate basal surfaces from the luminal
compartment [33, 34].
VE-Cadherin promotes proper localization of polarity markers
What is the basis for initiating polarity in the first place? In the case of extracellular lumen
formation, ECs first coalesce into cords where they adhere to each other via adherens
junctions. Numerous markers, such as β-catenin and N-cadherin, constitute adherens
junctions in multiple cell types. Vascular endothelial (VE)-cadherin (also known as Cdh5),
however, specifically marks junctions in ECs [35]. Far from simply labeling cell-cell
junctions, VE-cadherin plays a critical role in vascular morphogenesis. VE-cadherin
deficiency in mice results in early embryonic lethality due to severe vascular defects,
including failed establishment of yolk sac vasculature, disorganized and disconnected
embryonic vessels, and notably, minimal or absent lumens [36, 37]. A functional vascular
network also fails to form in VE-cadherin-depleted zebrafish embryos in which vessel
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lumens are small (or absent) and fail to connect to form a complete circulatory loop [38]. In
the adult, VE-cadherin is essential for maintaining vascular homeostasis and endothelial
barrier integrity [39, 40].
Subsequent studies in cultured ECs as well as in vivo have determined that the molecular
basis for aberrant lumen morphogenesis in VE-cadherin-deficient animals is associated with
impaired establishment of cell polarity. In VE-cadherin null mouse DAs, apical markers
such as CD34, PODXL, and Moesin fail to localize to the cell-cell contact, and consequently
lumens do not form [17]. These results were confirmed in detailed analyses of VE-cadherin-
depleted zebrafish where it was noted that Moesin was no longer enriched at the luminal
surface of the ISVs [19]. In addition, the distribution of ZO-1-containing junctions was
disorganized in VE-cadherin-depleted zebrafish, indicating a role for VE-cadherin in
maintaining adherens junctions as well as tight junctions. Tubular HUVEC networks in
collagen matrices also display specific localization of apical and basal markers [26].
However, in the absence of VE-cadherin, PODXL and collagen IV are aberrantly localized
with little distinction between apical and basal membranes. Consequently, there are multiple
small lumens instead of one central compartment (Fig. 3). In addition, members of the Par
complex are also absent from cell-cell contacts in VE-cadherin-depleted cells [26].
Moreover, VE-cadherin has been shown to directly associate with Par3 and Par6 in cultured
ECs, strongly suggesting that the interplay between junctional and polarity molecules
promotes lumen formation [41]. Interestingly, VE-cadherin is not required for polarity
during PLA anastomosis. Instead, it is needed to stabilize the initial contact made between
fusing sprouts, implying diverse roles for this junctional marker during various steps of
vascular assembly [22].
Small GTPases modulate the cytoskeleton to facilitate lumen formation
In addition to cell-cell contact and the establishment of polarity, lumen morphogenesis
requires cells to make dynamic contacts with the underlying ECM as well as rearrange their
internal actin cytoskeleton to adopt a suitable shape conducive to expansion of the luminal
compartment. Directly involved in regulating cell motility and cytoskeletal organization, the
Rho family of small GTPases has been at the forefront of cell biology for decades. The
number of studies on their downstream effectors, roles in diverse biological processes such
as gene expression, proliferation, and membrane trafficking, and implications for human
health is continually growing [42–44]. The most well-known GTPases, RhoA, Rac1, and
Cdc42, have been extensively characterized in fibroblasts, where they have critical roles in
organizing the actin cytoskeleton during cell migration and mitosis [45–48]. It is therefore
unsurprising that ECs also depend on GTPase activity for a multitude of cellular behaviors.
However, the functions of the Rho GTPases in vascular development and disease are only
just beginning to be uncovered, including their roles in lumen formation.
Rac1 and Cdc42 positively regulate lumen formation
Rac1 and Cdc42 are classically known to promote lamellipodial and filopodial protrusions,
respectively, at the leading edge of migrating cells including fibroblasts, ECs, and smooth
muscle cells [46, 49, 50]. Early cell culture studies first showed that Rac1 and Cdc42 have
distinct functions in ECs, such as stabilizing cell-cell junctions to regulate vascular
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permeability and mediating downstream signaling in response to shear stress [51–57].
Although global Rac1 inactivation in mice results in defects far preceding vascular
development, endothelial-specific ablation of Rac1 results in embryonic lethality at slightly
later stages with severe defects in angiogenic sprouting and remodeling of secondary vessels
[58, 59]. Genetic inactivation of Rac1 in cultured ECs reinforced the requirement for Rac1
in adhesion, migration, and tube assembly [59]. Similarly, global ablation of Cdc42 also
results in early developmental abnormalities prior to vessel development [60]; however,
mouse embryonic stem cells devoid of Cdc42 fail to assemble into vascular networks during
embryoid body differentiation due to impaired directional migration [61]. Very recently, an
endothelial-specific Cdc42-null mouse has been generated and displays severe defects in
overall vasculogenesis likely due to increased EC apoptosis [62].
Rac1 and Cdc42 have been strongly implicated in promoting formation of epithelial tubes
and therefore, have recently been the targets of study during vascular tubulogenesis [63–65].
Indeed, inhibiting Rac1 or Cdc42 activity or expression in HUVECs suspended in collagen
matrices prevents cell vacuolation and subsequent lumen formation [31, 66]. Furthermore,
signaling downstream of Rac1 and Cdc42 that is associated with polarity (Par complex) and
cytoskeletal dynamics (Pak2/Pak4) is also required for intracellular lumen formation in
collagen matrices [31, 67, 68]. In vivo, Cdc42 localizes to intracellular vacuolar structures in
zebrafish ISVs; however, studies to examine whether depleting Cdc42 in these vessels
hinders lumen formation have yet to be performed [16]. In a mouse skin model of
angiogenesis, retroviral delivery of VEGF and a dominant negative form of Cdc42
decreased the size and number of perfusable vessels whereas the constitutively active form
promoted formation of lumens, thereby supporting a positive role for Cdc42 in lumen
generation [56]. Rac1 has also been linked to in vivo lumen formation through its interaction
with cerebral cavernous malformation-1 (CCM1) protein. In CCM1-depleted zebrafish
embryos, although lumens of major vessels form normally, the lumens of the smaller ISVs
fail to form, most likely because intracellular vacuoles are not generated [69]. In addition,
depleting CCM1 in HUVECs inhibits Rac1 activity, implying that GTPase signaling
downstream of CCM1 is necessary for lumen morphogenesis in microvessels. Taken
together, these studies support a function for Rac1 and Cdc42 in lumen generation,
additionally potentiating the hypothesis that intracellular lumen formation may indeed be a
mechanism by which small-caliber vessels open and expand.
RhoA activity must be tightly controlled during lumen formation
The major physiological outputs of RhoA-mediated signaling in various cell types include
the formation of focal adhesions between cells and their underlying substrates as well as
formation of stress fibers that promote actomyosin contraction [70, 71]. The role for RhoA
in lumen morphogenesis has been controversial. Early studies showed that disrupted RhoA
function had no effect on intracellular vacuole formation in collagen matrices [31, 66].
However, later studies demonstrated that disruption of microtubules using chemical agents,
an event known to activate RhoA, results in the collapse of lumens in three-dimensional
assays. This is prevented when RhoA activity is inhibited, implying that increased RhoA
activity in fact antagonizes the stability of tubular networks [72]. Furthermore, Xu et al.
recently showed that negative regulation of RhoA signaling via interaction between Ras-
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interacting protein 1 (RASIP1) and the GTPase activating protein (GAP) Arhgap29 is
required for lumen formation [73]. In the absence of either interacting protein, RhoA activity
increases but Rac1 and Cdc42 levels are decreased, in agreement with studies highlighting
the requirement for the latter two GTPases in lumen formation. Consequently, cultured and
mouse embryonic ECs are unable to maintain adhesion to the underlying ECM and display
polarity defects with improper localization of apical and basal markers [73]. These data
strongly suggest that de-regulation of RhoA activity prevents proper cell behaviors
associated with lumen formation.
However, results from a number of studies conflict with the hypothesis that RhoA
suppresses lumen formation and instead, propose a positive role for RhoA during this
process. Introduction of VEGF and a dominant negative form of RhoA in mouse skin
resulted in fewer new blood vessels, and of vessels that did form, most did not contain
lumens [74]. Further evidence highlighting a requirement for RhoA signaling was
demonstrated in the mouse DA, where normal lumen formation proceeds when F-actin and
non-muscle myosin II first localize to the apical surface between the two opposing ECs [17].
In the presence of a Rho kinase (ROCK) inhibitor, F-actin correctly positions at the cell-cell
contact; however, myosin II fails to colocalize with F-actin, thus resulting in defective
lumen formation. These results indicate that RhoA downstream signaling through ROCK is
required for the proper EC shape changes that facilitate opening of the luminal
compartment.
More recently, a study demonstrated that RhoA lies downstream of a transcriptional cascade
responsible for promoting proper EC adhesion, shape, and proliferation to facilitate vessel
assembly [75, 76]. The transcription factor CASTOR (CASZ1), previously implicated in
cardiac development [77] and genetically linked to hypertension and high blood pressure
[78], and its direct target Epidermal Growth Factor Like-Domain 7 (Egfl7) are required for
vessel branching and lumen formation in Xenopus embryos [76]. EGFL7 is an ECM-
associated protein exclusively secreted by ECs during embryonic development that has been
demonstrated to play a role in vessel morphogenesis [79, 80]. In CASZ1 and EGFL7-
depleted HUVECs, RhoA expression levels, and consequently activity, are significantly
diminished, resulting in reduced stress fiber and focal adhesion formation associated with
contractility defects and loss of adhesion between cells and their underlying substrate. These
defects can be rescued by reintroduction of EGFL7 strongly suggesting that the CASZ1/
Egfl7 transcriptional hierarchy is required for proper expression of RhoA and the cellular
outputs associated with its activation (Fig. 4) [76]. Therefore, these results would favor a
model by which RhoA is necessary for eliciting the proper EC behaviors (i.e. cell shape and
adhesion) for vascular morphogenesis to proceed. Whether reduced RhoA levels explain the
impaired lumen formation in CASZ1 and EGFL7-depleted Xenopus embryos remains to be
established. However, because these small GTPases likely have roles in numerous processes
during vascular development, this is a situation where small animal models can be
particularly valuable. Pharmacological inhibition or the use of caged morpholinos to inhibit
GTPase activity in specific tissues during a tightly controlled temporal window can be
useful in teasing apart these diverse roles [81–83]. Nonetheless, it is evident that too much
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or too little GTPase signaling, particularly RhoA, can be detrimental to vascular
morphogenesis.
Endothelial cells enclose around a central lumen via a novel mechanism
The molecular players and pathways discussed above have been deciphered based on two
primary mechanisms of lumen morphogenesis: intracellular lumen formation via vacuole
coalescence or membrane invagination and the formation of extracellular lumens via cell-
cell separation. Nonetheless, characterization of these mechanisms has been confined to
limited, albeit informative, vascular contexts, such as cultured ECs suspended in ECM
matrices, the mouse DA, and zebrafish ISVs. Recent evidence has elucidated a new
mechanism by which lumens form. Helker et al. demonstrated that the zebrafish common
cardinal veins (CCVs), which bifurcate from the major posterior cardinal vein, develop a
central compartment via a novel lumen ensheathment mechanism [84]. In this model,
specified angioblasts destined to become ECs of the CCV are first positioned in a monolayer
on top of the yolk syncytial layer (YSL). These cells then detach from the YSL and migrate
to the epidermal side, joining together and shaping a new lumen-containing tube located
between the YSL and the epidermis, prior to the commencement of circulation. The cells
continue to migrate as a sheet to extend the tube and connect it to the heart inflow tract.
Interestingly, although VE-cadherin was shown to be required for detachment and migration
of ECs during this process, establishment of apicobasal polarity does not appear to be a
prerequisite for lumen formation, based on the absence of the apical marker PODXL2.
Because the ECs are not initially in contact with each other during the detachment and
ensheathment steps, perhaps defining the apical surface between adjacent cells is
superfluous. However, it would be interesting to determine whether CCVs form properly in
Moesin-depleted fish or other polarity mutants.
Conclusions and Implications
With the amount of heterogeneity that occurs in different vascular beds throughout
embryonic and neonatal development, it would not be surprising to identify additional
mechanisms of lumen formation. The assembly of the vasculature through distinct processes
such as de novo EC coalescence into cords, angiogenesis, anastomosis, or in response to
mechanical forces such as blood flow, may directly influence how the lumen is generated,
expanded, and maintained. With advances in imaging technology and more detailed
understanding of the spatial and temporal requirements of critical molecules during vascular
morphogenesis, the discovery of novel lumen formation mechanisms or events that remodel
the vessel architecture is very likely (Table 1). In addition to examining how lumens of
embryonic vessels develop, it would be interesting to investigate how lumens are re-
established postnatally, such as in neoangiogenesis after injury or during vascular
regeneration in the heart following myocardial ischemia. Furthermore, the need for effective
cancer therapies continues to sustain drug development industries, and trials testing the
efficacy of anti-angiogenic therapies in controlling tumor vasculature growth are ongoing
[85]. Although the majority of current treatments are aimed at inhibiting vessel growth and
expansion in order to starve tumors of oxygen and induce shrinkage, a seemingly
contradictory idea know as “vascular normalization” has emerged [86]. The tumor
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vasculature is highly abnormal; vessels are tortuous, leaky, uneven, and disorganized.
Inducing tumor vessels and ECs to become more “normal” by stabilizing junctions and
recruiting mural cells to provide cohesive coverage of EC-lined tubes may lead to improved
perfusion of drugs and soluble factors directly to the tumor site as well as reduce the chance
of metastasis. Obviously, these outcomes are concomitant with the presence of an
impermeable, stable lumen. Thus, a greater understanding of lumen morphogenesis,
particularly the molecular players involved, may contribute to new approaches for
normalizing tumor vessels.
Abbreviations
BMP bone morphogenetic protein
CCV common cardinal vein
DA dorsal aorta
DLAV dorsal longitudinal anastomosing vessel
EC endothelial cell
ECM extracellular matrix
FGF fibroblast growth factor
HUVEC human umbilical vein endothelial cell
ISV intersegmental vessels
PLA palatocerebral artery
VEGF vascular endothelial growth factor
YSL yolk syncytial layer
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Mechanisms of blood vessel lumen formation. A: Intracellular lumens refer to hollow spaces
enclosed by a single EC and devoid of junctions. Intracellular lumen formation can be sub-
divided into two mechanisms. (i) During vacuole coalescence (top panel), individual ECs
generate vacuole-like structures through membrane internalization. The vacuoles fuse to
form a hollow compartment devoid of ECM. Therefore, when vacuolated cells assemble to
form a network, contacts between adjacent cells are made (purple rectangles) however no
junctions are found interrupting the cell-lumen boundary resulting in a unicellular tube. (ii)
In apical membrane invagination (middle panel), once two distinct vessels (blue vs. pink)
have established contact (purple oval), the luminal compartment is expanded by
invagination of the membrane (light blue/pink). The membrane continues to extend through
the point of contact resulting in one continuous lumen. Each cell now makes up a unicellular
tube containing an intracellular lumen within the patent vessel. B: During extracellular
lumen generation (bottom panel), ECs first form adherens junctions between their contact
surfaces to generate cord-like structures. These junctions become redistributed from the
center of the contact region to the periphery in order to allow a luminal compartment to take
shape between the cells. Thus, multicellular tubes are generated in which the lumen is
surrounded by two or more ECs that remain in contact with each other as well as with
adjacent cells.
Charpentier and Conlon Page 15























Lumen formation during vessel fusion. Unicellular tubes remodel into multicellular tubes by
cell splitting. A: Two unicellular tubes (blue and pink) are flanked by multicellular tubes
(green/yellow and red/brown) with junctions represented by purple ovals. B: Two cells
flanking the blue unicellular tube (yellow and pink) rearrange their junctions and approach
each other (black arrows) while the blue cell is forced to split to one side of the vessel (white
arrow). C: The yellow and pink cells establish a new contact (gray oval) and the blue cell
has narrowed to one side of the vessel incorporating into a multicellular tube. D: The second
unicellular tube (pink) is now flanked by the blue and red cells which rearrange their
junctions and approach each other (black arrows) forcing the pink cell to the opposite side
(white arrow). E: The blue and red cells establish a new contact (gray oval) and the whole
vessel is now comprised of multicellular tubes.
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Role of VE-Cadherin in establishment of polarity. In the presence of VE-Cadherin (left
panel), ECs establish proper polarity with a specified apical surface, as marked by proteins
such as the CD34 sialomucins, the ERM protein Moesin, and members of the Par polarity
complex, and a basal surface marked by ECM constituents and integrins. However, when
VE-Cadherin is absent (right panel), apical and basal markers are disorganized and fail to
localize to the appropriate surface resulting in smaller or absent vessel lumens.
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RhoA lies downstream of the CASZ1/Egfl7 transcriptional network. A: The zinc-finger
transcription factor CASZ1 binds to and activates expression of Egfl7 in ECs (top panel).
EGFL7 is then secreted to the ECM and by a yet unknown mechanism, promotes RhoA
expression and subsequent GTPase activity (star) leading to proper EC shape and adhesion
to the substrate (as indicated by blue lines). B: In the absence of CASZ1 (bottom panel),
transcriptional regulation of Egfl7 is dysregulated and RhoA expression is diminished
resulting in thin, elongated cells that no longer maintain adhesion to the substrate and
eventually round up and detach.
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Table 1
Molecular determinants that play diverse roles during lumen morphogenesis
Molecule Function/localization during lumen formation Model system Reference




[17, 19, 26, 36–38]
Par complex (Par3-Par6-aPKC) Promotes endothelial polarization; associates
with tight and adherens junctions
Mouse, cultured ECs [17, 31, 41, 87]
Moesin Localizes to apical membrane; recruits F-actin to
apical surface
Mouse, zebrafish [17, 19]
CD34/PODXL Localize to apical membrane; sialic acids
promote cell-cell separation
Mouse, cultured ECs [17, 26, 27]
Rac1/Cdc42 Localize to vacuolar structures; mediate




[16, 31, 55, 56, 66, 67,
69]
RhoA Positive and negative roles; modulates proper
adhesion to ECM and ROCK-mediated shape
changes
Mouse, cultured ECs [17, 72–74, 76]
Rasip1 Regulates RhoA activity with Arhgap29 to
promote lumen formation
Mouse, cultured ECs [73]
Casz1 Binds and maintains Egfl7 expression in ECs Xenopus, cultured ECs [76]
Egfl7 Secreted into ECM and required for initial
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